Guidelines for field surveys of the quality of medicines: A proposal

PLoS Medicine

Volumn 6, Issue 3, 2009, Pages 0252-0257

  Newton, Paul N ^a   Lee, Sue J ^a   Goodman, Catherine ^a   Fernández, Facundo M ^a   Yeung, Shunmay ^a   Phanouvong, Souly ^a   Kaur, Harparkash ^a   Amin, Abdinasir A ^a   Whitty, Christopher J M ^a   Kokwaro, Gilbert O ^a   Lindegårdh, Niklas ^a   Lukulay, Patrick ^a   White, Lisa J ^a   Day, Nicholas P J ^a   Green, Michael D ^a   White, Nicholas J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIMALARIAL AGENT; TUBERCULOSTATIC AGENT; DRUG;

CHECKLIST; CHEMICAL ANALYSIS; DRUG DEGRADATION; DRUG MANUFACTURE; DRUG PACKAGING; DRUG QUALITY; DRUG RESEARCH; EVIDENCE BASED PRACTICE; FORGERY; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH SURVEY; LOWEST INCOME GROUP; MEDICAL ETHICS; MEDICOLEGAL ASPECT; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; CHEMISTRY; DRUG CONTAMINATION; DRUG STABILITY; DRUG STORAGE; EPIDEMIOLOGY; HEALTH; INFORMATION PROCESSING; PROGRAM DEVELOPMENT; STANDARD;

DATA COLLECTION; DRUG CONTAMINATION; DRUG STABILITY; DRUG STORAGE; GUIDELINES AS TOPIC; PHARMACEUTICAL PREPARATIONS; PROGRAM DEVELOPMENT; QUALITY CONTROL; SAMPLING STUDIES; WORLD HEALTH;

EID: 63449084033     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000052     Document Type: Review

References (39)

1. Amin AA, Hughes DA, Marsh V, Abuya TO, Kokwaro GO, et al. (2004) The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Trop Med Int Health 9: 967-974.
2. Shakoor O, Taylor RB, Behrens RH (1997) Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Hlth 2: 839-845.
3. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ (2005) The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Med 2: e100. doi:10.1371/journal.pmed.0020100
4. Newton PN, Proux S, Green M, Smithuis F, Rozendaal J, et al. (2001) Fake artesunate in southeast Asia. Lancet 357: 1948-1950.
5. Newton PN, Rozendaal J, Green M, White NJ (2002) Murder by fake drugs-Time for international action. BMJ 324: 800-801.
6. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, et al. (2006) Manslaughter by fake artesunate in Asia-Will Africa be next? PLoS Med 3: e197. doi:10.1371/journal.pmed.0030197
7. Newton PN, Green MD, Fernández FM, Day NJP, White NJ (2006) Counterfeit anti-infective medicines. Lancet Infect Dis 6: 602-613.
8. Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, et al. (2008) A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Med 5: e32. doi:10.1371/journal.pmed.0050032
9. Amin AA, Kokwaro GO (2007) Antimalarial drug quality in Africa. J Clin Pharm Ther 32: 429-440.
10. Syhakhang L, Lundborg CS, Lindgren B, Tomson G (2004) The quality of drugs in private pharmacies in Lao PDR: A repeat study in 1997 and 1999. Pharm World Sci 26: 333-338.
11. Wondemagegnehu E (1999) Counterfeit and substandard drugs in Myanmar and Viet Nam. WHO/EDM/QSM/99.3. Geneva: World Health Organization.
12. World Health Organization (2005) Counterfeit medicines: Some frequently asked questions. Available: http://www.wpro.who.int/media-centre/fact-sheets/fs- 20050506.htm. Accessed 24 February 2009.
13. Keoluangkhot V, Green M, Nyadong L, Fernandez F, Mayxay M, et al. (2008) Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor quality and underdosed intramuscular artemether. Am J Trop Med Hyg 78: 552-555.
14. Bate R, Coticelli P, Tren R, Attaran A (2008) Antimalarial drug quality in the most severely malarious parts of Africa - A six country study. PLoS ONE 3: e2132. doi:10.1371/journal.pone.0002132
15. Phanouvong S, Blum N, Smine A (2004) Guidelines for sampling of antimalarial drug samples in the USP DQI antimalarial drug quality monitoring project in Mekong sub-region countries. United States Pharmacopeia. Available: http://www.usp.org/pdf/EN/dqi/samplingGuidelines.pdf. Accessed 19 February 2009.
16. United States Pharmacopeia (2007) Ensuring the quality of medicines in resource-limited countries: An operational guide. Available: http://www.usp.org/worldwide/dqi/resources/technicalReports. Accessed 19 February 2009.
17. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, et al. (2004) Fake antimalarials in Southeast Asia are a major impediment to malaria control: Multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 9: 1241-1246.
18. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, et al. (2006) Counterfeit and substandard antimalarial drugs in Cambodia. Trans R Soc Trop Med Hyg 100: 1019-1024.
19. Basco LK (2004) Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am J Trop Med Hyg 70: 245-250.
20. Atemnkeng MA, De Cock K, Plaizier-Vercammen, J (2007) Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo. Trop Med Int Hlth 12: 68-74.
21. World Health Organization (2007) Survey of the quality of antiretroviral medicines circulating in selected African countries. Available: http://www.who.int/entity/medicines/publications/ARV-survey.pdf. Accessed 19 February 2009.
22. Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, et al. (2001) Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357: 1933-1936.
23. Amin AA, Snow RW, Kokwaro GO (2005) The quality of sulphadoxine- pyrimethamine and amodiaquine products in the Kenyan retail sector. J Clin Pharm Ther 30: 559-565.
24. Amin AA, Snow RW (2005) Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector. Malar J 26: 36.
25. Kaur H, Goodman C, Thompson E, Thompson K-A, Masanja I, et al. (2008) A nationwide survey of the quality of antimalarials in retail outlets in Tanzania. PLoS ONE 3: e3403. doi:10.1371/journal.pone.0003403
26. World Health Organization (2006) WHO guidelines for the treatment of malaria. Available: http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf. Accessed 19 February 2009.
27. Sans B (1999 April 1) Return to San Serriffe. The Guardian. Available: http://www.guardian.co.uk/theguardian/1999/apr/01/features11.g24. Accessed 19 February 2009.
28. Machin D, Campbell MJ, Fayers PM, Pinol APY (1997) Sample size tables for clinical studies. 2nd edition. Oxford: Blackwell Science.
29. Reinke WA (1991) Applicability of industrial sampling techniques to epidemiological investigations: Examination of an under-utilized resource. Am J Epidemiology 134: 1222-1232.
30. Lemeshow S, Taber S (1991) Lot quality assurance sampling: Single- and double-sampling plans. World Health Stat Q 44: 115-132.
31. Myatt M, Limburg H, Minassian D, Katyola D (2003) Field trial of the applicability of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma. Bull World Health Organ 81: 877-885.
32. Brixton Health (2008) SampleLQ. Available: http://downloads. biohealthmatics.com/downloads/0000000088.aspx. Accessed 19 February 2009.
33. Lanata CF, Black RE (1991) Lot quality assurance sampling techniques in health surveys in developing countries: Advantages and current constraints. World Health Stat Q 44: 133-139.
34. Robertson SE, Anker M, Roisin AJ, Macklai N, Engstrom K, et al. (1997) The lot quality technique: A global review of applications in the assessment of health services and disease. World Health Stat Q 50: 199-209.
35. Valadez JJ, Weiss W, Leburg C, Davis R (2003) Assessing community health programs-A trainer's guide using LQAS for baseline surveys and regular monitoring. Teaching-aids At Low Cost (TALC). Available: http://www.coregroup. org/working-groups/Intro.pdf. Accessed 19 February 2009.
36. SEARPharm Forum, World Health Organization (2007) Extent of spurious (counterfeit) medicines in India. Available: http://www.searpharmforum.org/ LinkFiles/Project-and-activities-CFM-Report.pdf. Accessed 19 February 2009.
37. Madden JM, Quick JD, Ross-Degnan D, Kafle KK (1997) Undercover care seekers: Simulated clients in the study of health provider behavior in developing countries. Soc Sci Med 45: 1465-1482.
38. EQUATOR Network (2008) Enhancing the QUAlity and Transparency Of health Research. Available: http://www.equator-network.org/. Accessed 24 February 2009.
39. Laing R, Vrakking H, Fourie B (2004) Quality and stability of TB medicines: Let the buyer beware! Int J Tuberc Lung Dis 8: 1043-1044.